FT218: “Once-at-bedtime FT218 at 9 g demonstrated a high degree of statistical signiﬁcance, compared to placebo, for each of the three co-primary endpoints“; Sleep disorder

sodium oxybate ER (FT218) - Avadel

Aug 19, 2021